ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1200706
CHEMBL1200706
Compound Name ALUMINUM HYDROXIDE
ChEMBL Synonyms SARPEP | ALU-CAP | ALMAGATE | LAS 3876 | ALUMINIUM HYDROXIDE | W 4600 | DIALUME | AMPHOJEL | ALGELDRATE | ALUMINUM HYDROXIDE | ALUDROX
Max Phase 4 (Approved)
Trade Names ALUDROX | DIALUME | AMPHOJEL | ALU-CAP | SARPEP
Molecular Formula H6AlO3

Additional synonyms for CHEMBL1200706 found using NCI Chemical Identifier Resolver

Compound Representations

Molfile Download MolFile
Canonical SMILES [OH-].[OH-].[OH-].[Al+3]
Standard InChI InChI=1S/Al.3H2O/h;3*1H2/q+3;;;/p-3
Standard InChI Key WNROFYMDJYEPJX-UHFFFAOYSA-K

Sources

  • British National Formulary
  • Orange Book
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Alternate Forms of Compound in ChEMBL


CHEMBL1200706

Molecule Features

CHEMBL1200706 compound icon
Drug Type:Inorganic Rule of Five:N First In Class:N Chirality:Achiral Molecule Prodrug:N Oral:Y Parenteral:N Topical:N Black Box:N Availability Type:Over-The-Counter

Mechanism of Action

Mechanism of Action ChEMBL Target References
Unknown Not Available

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Influenza in BirdsD005585EFO:0005222avian influenza1ClinicalTrials
Pneumonia, PneumococcalD011018EFO:1001474pneumococcal pneumonia2ClinicalTrials
Influenza, HumanD007251EFO:0001669influenza infection1ClinicalTrials
HIV InfectionsD015658EFO:0000764HIV infection1ClinicalTrials
Leishmaniasis, CutaneousD016773EFO:0005046cutaneous Leishmaniasis1ClinicalTrials
StomatitisD013280EFO:1001904oral mucositis2ClinicalTrials
Diabetes Mellitus, Type 1D003922EFO:0001359type I diabetes mellitus2ClinicalTrials
Severe Acute Respiratory SyndromeD045169EFO:0000694severe acute respiratory syndrome1ClinicalTrials
Campylobacter InfectionsD002169EFO:0007190campylobacteriosis1ClinicalTrials
Staphylococcal InfectionsD013203EFO:0005681Staphylococcus aureus infection1ClinicalTrials
Tobacco Use DisorderD014029EFO:0003768nicotine dependence2ClinicalTrials
Respiratory Syncytial Virus InfectionsD018357EFO:1001413Respiratory Syncytial Virus Infection1ClinicalTrials

Clinical Data

ClinicalTrials.gov ALUMINUM HYDROXIDE
The Cochrane Collaboration ALUMINUM HYDROXIDE

Calculated Compound Parent Properties

Mol. Weight Mol. Weight Monoisotopic ALogP #Rotatable Bonds Polar Surface Area Molecular Species
81 81.0132 - - - -


HBA HBD #Ro5 Violations HBA (Lipinski) HBD (Lipinski) #Ro5 Violations (Lipinski)
- - - - - -


ACD Acidic pKa ACD Basic pKa ACD LogP ACD LogD pH7.4 Aromatic Rings Heavy Atoms QED Weighted
- - - - - - -0

Structural Alerts

There are no structural alerts for CHEMBL1200706

Compound Cross References

ATC A - ALIMENTARY TRACT AND METABOLISM
A02 - DRUGS FOR ACID RELATED DISORDERS
A02A - ANTACIDS
A02AB - Aluminium compounds
A02AB02 - algeldrate

A - ALIMENTARY TRACT AND METABOLISM
A02 - DRUGS FOR ACID RELATED DISORDERS
A02A - ANTACIDS
A02AD - Combinations and complexes of aluminium, calcium and magnesium compounds
A02AD03 - almagate

A - ALIMENTARY TRACT AND METABOLISM
A02 - DRUGS FOR ACID RELATED DISORDERS
A02A - ANTACIDS
A02AB - Aluminium compounds
A02AB01 - aluminium hydroxide

ChemSpider ChemSpider:WNROFYMDJYEPJX-UHFFFAOYSA-K
Wikipedia Aluminium_hydroxide

UniChem Cross References

View the UniChem Connectivity matches for CHEMBL1200706



ACToR 21645-51-2
ChEBI 33130
ChemicalBook CB9243680
DrugBank DB06723
DrugCentral 4250
eMolecules 713199 478576
EPA CompTox Dashboard DTXSID2036405
FDA SRS 5QB0T2IUN0
KEGG Ligand C13391
MolPort MolPort-003-925-508
Nikkaji J95.831J
PubChem 10176082
PubChem: Thomson Pharma 15170361 16031799
SureChEMBL SCHEMBL1539

UniChem REST Service Call:
https://www.ebi.ac.uk/unichem/rest/verbose_inchikey/WNROFYMDJYEPJX-UHFFFAOYSA-K spacer
spacer